Searched for
STERILE INJECTABLES MANUFACTURER
HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
After Gurgaon’s Rs 70 lakh fake Mounjaro seizure, more stocks found in Hyderabad; Racket may span multiple statesThe investigation into fake Mounjaro injections has widened beyond NCR after authorities confirmed that part of the seized batch was sent t...
Quadria, PE funds eye stake in Samarth Lifesciences; deal may value firm at Rs 4,500 croreQuadria Capital is eyeing a strategic acquisition of a majority interest in Samarth Lifesciences, a move that could value the transaction a...
Jubilant Pharmova arm to invest $300 mn in US by FY28 to double sterile injectable capacityJubilant HollisterStier LLC is investing USD 300 million by FY28 to double its sterile injectable manufacturing capacity in the US. The com...
Onyx Biotec shares debut at 11% discount on NSE SME platform todayOnyx Biotec share price: Onyx Biotec's shares debuted on the NSE SME platform at Rs 54.05, below the issue price of Rs 61. The company rais...
Dr Reddy's joins hands with Gland Pharma to market 8 ANDAs in USDr Reddy's is developing its injectable business and recently launched Paricalcitol injection, a therapeutic equivalent generic version of ...
Swedish firm Recipharm buys majority stake in Nitin Lifesciences for Rs 671 croreSwedish contract drug manufacturing firm Recipharm has acquired a 74% stake in Nitin Lifesciences, a privately held sterile injectables man...
Claris Lifesciences Q2 net profit falls 43.65 pc to Rs 18.2 crSterile injectables manufacturer Claris Lifesciences today reported a 43.65 per cent decline in net profit at Rs 18.2 crore for the second ...
- Strides Arcolab's Polish sterile facility gets USFDA nod
Strides Arcolab today said its injectables unit Agila Specialties has received US Food and Drug Administration (USFDA) approval for its Pol...
- PE funds eye stake in Strides' injectables biz
Private equity funds Carlyle Group and 3i, are among those holding preliminary discussions to take a substantial minority stake in pharmace...
- Pharma cos inject capacities to meet growing demand
Indian pharmaceutical companies with a presence in sterile injectables space are expanding capacities to cater to growing demand in this se...
- Strides Acrolab receives US FDA approval
The Rs 1000 crore generic pharma company has received US FDA inspection approval status for its steriles injectable complex at Bangalore.
- Aurobindo receives US FDA nod for bacterial infection drug
Drug maker Aurobindo Pharma said that it has received the US regulatory approval for its Cefazolin injection, used in the treatment of bact...
- Strides Arcolab gets approval for Fosphenytoin injection
Strides Arcolab has received its third abbreviated new drug application approval, for Fosphenytoin Injection 50mg/mL in 2 ml and 10 ml vial...
- Strides Arcolab receives USFDA approval for Tobramycin, Tazo Pip
Strides Arcolab has received second abbreviated new drug application approval for Tobramycin 40 mg/ml.
- Strides Arcolab inaugurates Brazil facility
Strides Arcolab on Friday said it has inaugurated its sterile injectable facility at Compos in Rio De Janeiro, Brazil.
- Wockhardt gets US nod for Cefotaxime injection
Wockhardt Ltd on Thursday said it has received approval from USFDA for marketing antibiotic Cefotaxime sodium injection in the US market.